Top companies in the Health Information Exchange Market| eClinicalWorks, Relayhealth Corporation, Cerner Corporation

Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care.

• The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.

What Drives the Market?

1. Strong Government Support and Initiatives
2. Increased Measures to Improve Healthcare Quality and Care Coordination Likely to Trigger HIE Adoption
3. Need to Curtail Healthcare Costs

HIE enables collaboration between healthcare stakeholders, cuts down on administrative tasks, and eventually provides greater transparency in the field of healthcare. HIE is an ever-changing concept. Continuously changing technological and regulatory environment consistently evolves the HIE space.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=238516643

The health information exchange market has been segmented, on the basis of type, into directed exchange, query-based exchange, and consumer-mediated exchange. The directed exchange segment accounted for the largest share of the global market in 2015. Directed exchange supports point-to-point transactions and transmits documents to physicians’ EHR; this is contributing to the large share of this segment.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

The health information exchange market in Asia-Pacific is expected to grow at the fastest rate during the forecast period. High growth in this regional segment can primarily be attributed to the growing initiatives for Japan’s EHR adoption and ICT fund, investments and reforms to modernize China’s healthcare infrastructure, rapidly growing Indian healthcare industry, implementation of HCIT programs in Australia & New Zealand, and One Singaporean One Health Record – one of the pioneer patient management programs in Singapore.

Some key players mentioned in the research report are:

The major players of the market are Allscripts Healthcare Solutions, Inc. (U.S.), Relayhealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), and eClinicalWorks (U.S.) among others.

Request Sample Report of Healthcare Information Exchange Market :@https://www.marketsandmarkets.com/requestsampleNew.asp?id=249987292

Aesthetic/Cosmetic Lasers Market 2020 Key Drivers and Restraints, Regional Outlook, End-User Applicants by 2021

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.

•    The global aesthetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021

Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) – Forecasts to 2021

Browse 88 market data tables and 43 figures spread through 147 pages
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94673613

Primary and secondary research was used to for market estimation and forecast. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market.

Aesthetic/Cosmetic Lasers Market segmented into :

Based on type, the aesthetic/cosmetic lasers type market is segmented into standalone lasers and multiplatform lasers. In this market, multiplatform lasers formed the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications.

Based on application, the aesthetic/cosmetic lasers type market is segmented into vascular lesions, acne & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynecological conditions). The hair removal segment accounted for the largest share of the market due to factors such as high adoption of aesthetic procedures, developments in the laser technology, increased focus on body appearance, and high disposable income.

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94673613

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

Geographical Growth Analysis:

The market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global aesthetic lasers market. However, the Asia-pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to factors changing lifestyles, rising incidences of skin damage, and increasing medical tourism in the region will drive the growth of this market.

Some of The Major Players In Aesthetic/Cosmetic Lasers Market :

Industry trends such as social media marketing and increasing consolidations of manufacturers and suppliers of aesthetic lasers products is further driving the growth of this market. Major players in the aesthetic lasers market include Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).

Global Cell Therapy Technologies Market to Receive Overwhelming Hike in Revenues by 2023

Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.

• The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period.

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023

What Drives the Market?

1. Rising Government Investments in Cell-Based Research
​​​​​​​2. Large Number of Oncology-Oriented Cell-Based Therapy Clinical Trials
3. Affordability and Sustainability of Advanced Cell Therapy Instruments

China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments. These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

Cell processing segment to witness the highest growth during the forecast period

Based on process, the cell therapy technologies market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is projected to witness the highest CAGR during the forecasted period.

The geographical regions mapped in the report are: 

1. North America
 2. Europe
 3. Asia-Pacific
4. Rest of the World (RoW)

North America to dominate the cell therapy technologies market during the forecast period

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018 owing to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries. The Asia Pacific region is expected to register the highest CAGR during the forecast period. The increasing demand for cell therapy instruments and products from China, India, and Japan primarily due to the increasing research funding for vaccine development and changing disease profiles is supporting the growth of the market in the Asia Pacific.

Some key players mentioned in the research report are:

Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

To get a 10% Customization on the report, click @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978

COVID 19 Impact on Ambulatory Surgical Centers Market | Opportunities, Key Players, Competitive and Regional Analysis by Forecast 2025

A majority of this growth is attributed to the growing need to curtail escalating healthcare costs, shift from inpatient to outpatient surgical procedures, growing demand for IT solutions such as mhealth, telehealth, and remote patient monitoring for better management, and the need to improve the quality of healthcare while maintaining the operational efficiency of healthcare organizations.

Market Dynamics
1. Increasing number of Ambulatory Surgical Centerss
2. Need to curtail escalating healthcare costs
3. Growing use of IT solutions among ASCs

The Ambulatory Surgical Centers market is projected to reach USD 7.2 billion by 2025 from 2.1 billion in 2020, at a CAGR of 27.6% during the forecast period. 

In 2019, Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), and NextGen Healthcare (US) were some of the major players in the Ambulatory Surgical Centers market.

Based on the products and services, the clinical solutions segment accounted for the largest share of the Ambulatory Surgical Centers market in 2019. There is a high demand for clinical solutions due to the increasing demand for improved patient safety and patient care, the need to manage complex patients’ data from different medical devices and information systems, and the need for integrated healthcare systems

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182183086

Key Questions Addressed by the Report:

1. Who are the top 10 players operating in the global Ambulatory surgical centers market?
2. What covers the drivers, restraints, opportunities, and challenges in the Ambulatory surgical centers market?
3. What are the new technological advancements in the Ambulatory surgical centers market?
4. What are the growth trends in the Ambulatory surgical centers market at the segmental and overall market levels?

The report claims to split the Regional Scope of the Ambulatory surgical centers market into

• North America (US and Canada)
• Europe (Germany, France, UK, Rest of Europe)
• Asia-Pacific (Japan, Rest of Asia Pacific
• Rest of World (Latin America, Middle East & Africa)

North America will continue to dominate the Ambulatory surgical centers market during the forecast period

North America accounted for the largest share of the Ambulatory surgical centers market, followed by Europe. The large share of this region can be attributed to the high adoption of Ambulatory surgical centers for reducing the soaring healthcare costs, increasing volume of surgical procedures performed, and the presence of significant market players, such as Epic Systems Corporation (US), Cerner Corporation (US), McKesson Corporation (US), Philips Healthcare (Netherlands), and Allscripts Healthcare Solutions, Inc. (US).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=182183086

Key Players and Strategies Adopted by Them:

Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions, Inc. (US), GE Healthcare (US), Philips Healthcare (Netherlands), athenahealth, Inc. (US), Optum (US), Epic Systems Corporation (US), Medical Information Technology, Inc. (MEDITECH) (US), eClinicalWorks (US), athenahealth, Inc. (US), Advanced Data Systems Corporation (US), NextGen Healthcare (US), CureMD (US), HST Pathways (US), and Surgical Information Systems (US).

Anatomic Pathology Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2024

According to the new market research report “Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) – Global Forecast to 2024″, , published by MarketsandMarkets™, The anatomic pathology market is estimated to grow from USD 33.0 billion in 2019 to USD 44.4 billion by 2024, at a CAGR of 6.1%.

However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent during the forecast period.

Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) – Global Forecast to 2024

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

The Anatomic Pathology Market is Segmented on:

1. Product & Service
2. Consumables
3. Application
4. End User

Services segment to witness the highest growth during the forecast period
By product & service, the market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period.

Disease diagnosis segment accounted for the largest share of the anatomic pathology market, by application, in 2018
Based on application, the market is segmented into disease diagnosis and medical research. The market for disease diagnosis is further segmented into cancer and other diseases. In 2018, the disease diagnosis segment accounted for the largest market share.

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

The geographical regions mapped in the report are:

•  North America
• Europe
• Asia Pacific
• Rest of the World

North America is the largest regional market for anatomic pathology

In 2018, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the market in North America.

Some key players mentioned in the research report are:

Prominent players in anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).

Professional Analysis of How COVID-19 is Impacting the Wireless Health Market

 Growth in the overall market can largely be attributed to factors such as increasing advancements in wireless communication technologies, growing internet penetration, increasing utilization of connected devices in the management of chronic diseases, rising adoption of a patient-centric approach by healthcare providers, robust penetration of 3G and 4G networks in healthcare services, and mainstreaming of cloud computing.

 The global wireless health market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period of 2015 to 2020. 

Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), Component (Hardware, Software, & Services), Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) – Analysis & Global Forecast to 2020
 

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551

On the basis of components, the market is segmented into hardware, software, and services. The software segment accounts for the largest share of the global market in 2015. Increasing adoption of healthcare IT solutions and growing need for upgrading the existing software are the major driving factors for the growth of this market.

On the basis of technology, the market of wireless health is further segmented into WPAN, WLAN/WiFi, WiMAX, and WWAN. The WPAN technology market segment accounts for the largest share in the market in 2015. WPAN technologies are highly secure and affordable, making them one of the most widely adopted wireless health technologies. The WPAN technology segment is further segmented into Bluetooth, RFID, Ant+, ZIgbee, Z-wave, and UWB.

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=551

On the basis of end users, the market of wireless health is further segmented into providers, payers, and patients/individuals. The providers segment accounts for the major share of the global market in 2015.

Lack of skilled IT professionals and data security concerns are expected to restrain the growth of the market to a certain extent. In addition, lack of data management and interoperability issues pose as major challenges for the market. On the basis of region, this market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Key Market Players

Allscripts Healthcare Solutions, Inc. (U.S.), AT &T, Inc. (U.S.), Cerner Corporation (U.S.), Omron Corporation (U.S.), Philips Healthcare (U.S.), Verizon Communications, Inc. (U.S.), Qualcomm, Inc. (U.S.), Aerohive Networks, Inc.(U.S.), Vocera Communications, Inc. (U.S.), and Alcatel-Lucent (U.S.) are some of the key players in the wireless health market worldwide.

Get More Information @https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=551

Vaccine Adjuvants Market Analysis and Opportunities During COVID-19 Pandemic

The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases.

• The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.
  

What Drives the Market?

1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases
4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants

The research applications segment is expected to account for the largest share of the market during the forecast period. The human vaccine adjuvants segment is expected to account for the largest share of the global market in 2016 and is expected to have a higher growth rate in the application category segment.

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016.

On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

The vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries

Some key players mentioned in the research report are:

Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Get Sample Report @https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Pharmacy Automation Market in Medication Dispensing System | Robot & Carouse

The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost.

• Pharmacy automation market is estimated to grow from USD 3.63 billion in 2017 to USD 5.38 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.

Driver: Growing need to minimize medication errors

Medication errors and dispensing errors are recognized as leading causes of hospital readmissions across the globe. A medication error can occur due to a variety of factors such as poor order communication between the physician and pharmacist, dangerous storage practices in pharmacies, and confusion arising out of the use of similar labels. Automated systems are considered to be one of the most efficient solutions to minimize these errors.

Browse in-depth TOC on “Pharmacy Automation Market”
181 – Table
54 – Figures
218 – Pages

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71522890

By product, the automated medication dispensing systems segment accounted for the largest share of the pharmacy automation market

Based on product, the pharmacy automation market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy automation systems. Automated medication dispensing systems accounted for the largest share of the pharmacy automation market in 2016.

By end user, the retail pharmacies segment to record the highest CAGR during the forecast period

On the basis of end users the market is classified into inpatient pharmacies, outpatient pharmacies, pharmacy benefit management organization and mail order pharmacies, and retail pharmacies. Retail pharmacies is the fastest growing end user segment in the pharmacy automation market during the forecast period.

Request Sample Report : https://www.marketsandmarkets.com/requestsampleNew.asp?id=71522890

The geographical regions mapped in the report are:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

North America to account for the largest market size during the forecast period :

North America is expected to hold the largest market size in the pharmacy automation market during the forecast period, followed by the European region. The large share of the N+0orth American pharmacy automation market can largely be attributed to the increasing number of drug prescriptions at resulting from growth in the aging population.

Some key players mentioned in the research report are:

Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst Systems, LLC (U.S.).

Radiation Dose Management Market worth $447 million by 2024 to Reflect Impressive Growth in North America Region

Growth in the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.

• The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7% during the forecast period.

By modality, the market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, mammography, and nuclear medicine. The computed tomography segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the increasing number of CT examinations worldwide and the rising awareness of radiation dose exposure.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344

Based on product & service, the market is segmented into radiation dose management solutions and radiation dose management services. The radiation dose management solutions segment is projected to witness the highest growth during the forecast period. The increasing adoption of radiation dose management solutions by healthcare providers owing to the growing regulations regarding ionizing radiation across the globe is the major factor supporting the growth of this segment.

Based on end user, the market is segmented into hospitals, ambulatory care settings, and other end users. The hospitals segment accounted for the largest share of the market in 2018. The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, and the increasing awareness of the harmful effects of radiation exposure are some of the major factors responsible for the high demand for radiation dose management solutions in hospitals.

The geographical regions mapped in the report are:

• North America
• Europe
• Asia Pacific
• Rest of the World

Request Sample Report of radiation dose management Market:: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82326344

Regional Growth, Development and Demand Analysis:

North America accounted for the largest share of the radiation dose management market in 2018 :
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market. The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies.

Some key players mentioned in the research report are:
Key players in the global radiation dose management industry are Bayer AG (Germany), GE Healthcare (US), PACSHealth, LLC (US), and Sectra Medical Systems (Sweden). Other prominent players in this market include Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (US), Siemens Healthineers (Germany), Agfa HealthCare (Belgium), Canon (Japan), and Qaelum N.V. (Belgium).

Health Information Exchange Market : Increasing Investments in the HealthcareIT Market

Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care.

• The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.

What Drives the Market?

1. Strong Government Support and Initiatives
2. Increased Measures to Improve Healthcare Quality and Care Coordination Likely to Trigger HIE Adoption
3. Need to Curtail Healthcare Costs

HIE enables collaboration between healthcare stakeholders, cuts down on administrative tasks, and eventually provides greater transparency in the field of healthcare. HIE is an ever-changing concept. Continuously changing technological and regulatory environment consistently evolves the HIE space.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=238516643

The health information exchange market has been segmented, on the basis of type, into directed exchange, query-based exchange, and consumer-mediated exchange. The directed exchange segment accounted for the largest share of the global market in 2015. Directed exchange supports point-to-point transactions and transmits documents to physicians’ EHR; this is contributing to the large share of this segment.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

The health information exchange market in Asia-Pacific is expected to grow at the fastest rate during the forecast period. High growth in this regional segment can primarily be attributed to the growing initiatives for Japan’s EHR adoption and ICT fund, investments and reforms to modernize China’s healthcare infrastructure, rapidly growing Indian healthcare industry, implementation of HCIT programs in Australia & New Zealand, and One Singaporean One Health Record – one of the pioneer patient management programs in Singapore.

Some key players mentioned in the research report are:

The major players of the market are Allscripts Healthcare Solutions, Inc. (U.S.), Relayhealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), and eClinicalWorks (U.S.) among others.

Request Sample Report of Healthcare Information Exchange Market :@https://www.marketsandmarkets.com/requestsampleNew.asp?id=249987292